We Are Donating to the Bundesverband Kinderhospiz e.V.

We Are Donating to the Bundesverband Kinderhospiz e.V.

The reflective season of the year has begun, and we would like to take this opportunity to thank you for the trust you have placed in us. The Christmas season reminds us of the importance of safety and health—values that guide our daily work in medicine.

This year, we are therefore donating €10,000 to the Bundesverband Kinderhospiz e.V.

We greatly appreciate your loyalty and collaboration, and we wish you and your families a joyful Christmas and a successful start to the coming year.

The work of this association in support of seriously ill children and their families moves us deeply. As a pharmaceutical manufacturer in the field of nuclear medicine—especially in cancer diagnostics—we are acutely aware of our responsibility toward those who rely on help the most. As a company dedicated to the well-being of patients and the improvement of quality of life, it is important to us to have a positive impact on society beyond the field of medicine.

We firmly believe that public awareness of issues such as the care of seriously ill children should be strengthened to foster solidarity and compassion. With our donation, we hope to bring comfort and support to families during difficult times.

Ähnliche Beiträge

Saxon State Parliament member Thomas Schmidt visits ROTOP

August 7th, 2026|

August 7, 2026 - A reunion with a long-standing companion: Saxon State Parliament member Thomas Schmidt visited our Radiopharmacy to learn about its development since its inauguration in 2020. The discussions focused on the future of radiopharmacy and nuclear medicine as well as the European framework for innovative diagnostic and therapeutic approaches.

New CFO at ROTOP – Dr. Michael Peterseim

March 13th, 2026|

March 13, 2026 - We’re pleased to Welcome Dr. Michael Peterseim as our new Chief Financial Officer (CFO) at ROTOP. Dr. Peterseim brings many years of experience in financial leadership and has successfully guided companies through transformation processes, strengthened performance, and executed strategic transactions, particularly in growth situations.

Go to Top